Valiant Organics, a business that specialises in the production and marketing of specialty chemicals used in a variety of industries, including agrochemicals, pharmaceuticals, dyes, pigments, and veterinary medications, is scheduled to start producing Ortho Amino Phenol (OAP) and Pharma Intermediates in Q2 FY23.
Ortho Amino Phenol (OAP) phase 1 production will begin in the second quarter of FY23. A portion of the production will be used to do forward integration for one of the company’s current products. A total of 15 crore has been invested by the firm on capex for OAP. The company just completed a fruitful trial run. Pharmaceutical intermediate manufacture is scheduled to begin in Q2 of FY23.
This facility serves a variety of functions for forward integration within the Group firm and produces API raw materials N-1 and N-2. The company has spent a total of ₹60 crore on capex.
